Overview

Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
To investigate safety, tolerability and anti-viral activity in Integrase-Naïve HIV-1 infected adults
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline